| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.16 | 0.3 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |